Clinical trials
Full profile accessFollow clinical development from study design and recruitment through results.
- Trial phase
- Status
- Readouts
Drug intelligence / Profile preview
Nano-silver gel is a topical antimicrobial product that contains silver nanoparticles suspended in a gel formulation. It's used primarily for wound management and treating various skin conditions due to its antibacterial properties. Nano-silver gel contains silver nanoparticles with particle sizes typically ranging from 1-20 nanometers. These tiny silver particles provide a large surface-to-volume ratio that enhances their antimicrobial activity. The gel formulation often includes pharmaceutically acceptable excipients such as carbomer, polycarbophil, or polyethylene glycol, along with dispersants and wetting agents like glycerol. It exhibits broad-spectrum antimicrobial activity against bacteria, fungi, and viruses due to the unique physicochemical properties of nanosilver. The gel is primarily used for wound management, treating skin infections, and as a topical antimicrobial agent.
Beyond the preview
Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.
Follow clinical development from study design and recruitment through results.
Explore development by indication, patient population, and geography.
Trace asset ownership, licensing agreements, and commercial partnerships.
Explore the patent landscape and regulatory exclusivity around an asset.
Compare development programs by target, modality, and indication.
Connect source evidence and development news to your research questions.
See how Gosset can support your research on nano-silver gel.